Skip to content

Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Compare within a sector
MetricAZNAstraZeneca PLCNVSNovartis AGMRKMerck & Co.
Snapshot
Price$157.00$140.87$143.90
Market cap$284.73B$261.56B$319.99B
Valuation
P/E24.1x19.5x39.6x
Forward P/E18.1x17.9x56.6x
Growth
Revenue growth9.9%5.8%2.9%
EPS growth33.7%9.3%-48.3%
Profitability
Net margin17.2%24.1%13.6%
ROE22.3%31.7%17.9%
Balance sheet & cash
Debt / equity0.61x0.77x0.94x
Free cash flow yield3.1%4.2%2.9%
Dividend yield1.7%2.9%3.0%
Verdict
Investment ratingFavorable· 68Favorable· 67Weak· 40

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

YearAZNtoday $157NVStoday $141MRKtoday $144
2027$157.44 – $230.92+47% CAGR$115.45 – $169.32+20% CAGR$110.08 – $161.46+12% CAGR
2028$210.52 – $308.76+40% CAGR$126.15 – $185.02+15% CAGR$112.29 – $164.68+7% CAGR
2029$281.48 – $412.84+38% CAGR$137.84 – $202.17+13% CAGR$114.53 – $167.98+5% CAGR
2030$376.37 – $552.01+37% CAGR$150.62 – $220.91+12% CAGR$116.82 – $171.34+4% CAGR
2031$503.25 – $738.09+36% CAGR$164.58 – $241.39+11% CAGR$119.16 – $174.76+4% CAGR
5-yr CAGR26.2% – 36.3%3.2% – 11.4%-3.7% – 4.0%